Bush Tia L 4
4 · Centessa Pharmaceuticals plc · Filed Sep 24, 2025
Insider Transaction Report
Form 4
Bush Tia L
Chief Technology & Quality Ofc
Transactions
- Exercise/Conversion
Ordinary Shares
2025-09-24$9.42/sh+35,000$329,700→ 156,503 total - Exercise/Conversion
Share Option (right to buy)
2025-09-24−35,000→ 440,338 totalExercise: $9.42Exp: 2031-05-07→ Ordinary Shares (35,000 underlying) - Sale
Ordinary Shares
2025-09-24$24.00/sh−35,000$840,000→ 121,503 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024.
- [F3]25% of the shares subject to such option shall vest and become exercisable on May 20, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.